6-methyl-2-ethyl-3-hydroxypyridine and Coronary Artery Disease

6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Coronary Artery Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kalinina, EV; Lilitsa, GV; Zaslavskaia, RM	1

Other Studies

1 other study(ies) available for 6-methyl-2-ethyl-3-hydroxypyridine and Coronary Artery Disease

Article	Year
[Efficacy of emoxypine in combined therapy for elderly patients with postinfarct cardiosclerosis and heart failure]. Klinicheskaia meditsina, 2004, Volume: 82, Issue:12 Topics: Adrenergic beta-Antagonists; Aged; Coronary Artery Disease; Diuretics; Drug Therapy, Combination; Echocardiography, Doppler; Electrocardiography, Ambulatory; Female; Fibrinolytic Agents; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Myocardial Infarction; Picolines; Platelet Aggregation Inhibitors; Vasodilator Agents	2004

Article

Year

[Efficacy of emoxypine in combined therapy for elderly patients with postinfarct cardiosclerosis and heart failure].

Klinicheskaia meditsina, 2004, Volume: 82, Issue:12

Topics: Adrenergic beta-Antagonists; Aged; Coronary Artery Disease; Diuretics; Drug Therapy, Combination; Echocardiography, Doppler; Electrocardiography, Ambulatory; Female; Fibrinolytic Agents; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Myocardial Infarction; Picolines; Platelet Aggregation Inhibitors; Vasodilator Agents

2004